Loading the map…
Other professional, scientific and technical activities n.e.c. · Wembley, Middlesex
Fadek Pharma
Fadek Pharma Limited
Private limited company registered in Wembley, classed under “Other professional, scientific and technical activities n.e.c.”.
Headline figures
FY to Jul 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2025 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees | ||
| Retained reserves |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2025 | 2025 |
|---|---|---|
| Fixed assets | ||
| Current assets | ||
| of which debtors | ||
| of which cash | ||
| Net current assets | ||
| Net assets |
6 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Fadek Pharma do?
Private limited company registered in Wembley, classed under “Other professional, scientific and technical activities n.e.c.”.
›How much turnover does Fadek Pharma make?
Answered in the full report
›Is Fadek Pharma profitable?
Fadek Pharma's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Fadek Pharma?
Answered in the full report
›Where is Fadek Pharma based?
Its registered office is 21 Barn Rise, Wembley, Middlesex, HA9 9NQ, in Wembley, Middlesex.
›When was Fadek Pharma founded?
Fadek Pharma Limited was incorporated on 26 July 2024.
›Is Fadek Pharma still trading?
The register lists Fadek Pharma Limited as active.